Opinion: STAT+: I’m a cardiologist. I’m a little puzzled about the blockbuster new study on deprescribing statins
As I listened to the results of the STREAM trial — which found that older adults without a history of heart attacks or strokes who stopped taking statins didn’t have significantly different outcomes from those who continued taking them — I jotted down that the study continued the theme.
- At the American Heart Association’s recent annual meeting, the overarching theme coming from the center stage, bathed in Pantone red, was one of high-profile neutral findings.
- Theoretically, this scenario can happen in noninferiority studies, where researchers are testing whether an intervention offers similar outcomes compared with a standard.
- Continue to STAT+ to read the full story….
De-prescribing statins in this group, by the expectations set by researchers at the beginning of STREAM, was technically noninferior, but nevertheless, still inferior.
- But as the Kaplan-Meier curves were cast onto the screen, something felt off: The curves diverged, rather than stayed together.
- The patients randomized to stop taking their statin did worse compared with those who continued.
How this summary was made: extractive summary — built from the sources' own reporting. It is drawn only from the reporting of the sources listed below — read the originals for full detail. How we summarize →